Industry, Lawmakers Rally for Drug Coupons
Healthcare officials and lawmakers in Massachusetts are demonstrating support of legislation to pave the way for consumers to use coupons-manufacturer discounts and co-pay assistance programs-to offset the rising costs of prescription drugs.
Massachusetts currently does not allow consumers to purchase prescription medications using coupons. A spokesperson for the Massachusetts Independent Pharmacists Association, said such coupons could in some cases save patients up to 75% on their co-pay for common medications. People find these coupons on the Internet and bring them into a pharmacy. Pharmacists, in Massachusetts, are then in the position of telling them they can't use them.
Previous attempts to pass similar legislation have been blocked by insurance companies claiming that such discounts eat into their profitability. Supporters say that if we're in a position to provide some financial relief, then we should.
http://www.bizjournals.com/boston/stories/2010/03/29/daily24.html?s=industry&i=health_care
Pfizer Gives Details on Payments to Doctors
The world's largest drug maker, Pfizer, announced this week that it paid about $20 million to 4,500 doctors and other medical professionals for consulting and speaking on its behalf in the last six months of 2009; this is Pfizer's first public accounting of payments to the people who decide which drugs to recommend.
Pfizer also paid $15.3 million to 250 academic medical centers and other research groups for clinical trials in the same six-month time period. The disclosures do not include payments outside the U.S.
Most of the disclosures were required by an integrity agreement the company signed in August to settle a federal investigation into the illegal promotion of drugs for off-label uses.
http://www.nytimes.com/2010/04/01/business/01payments.html
FDA Targets Ice on Frozen Seafood
(Editor's Note: This is not a drug-related topic but is interesting.)
The FDA is reviewing a multistate investigation that found shoppers have been paying for large amounts of ice that are not supposed to be included in the price of frozen seafood. Their investigation found that a coating of ice applied to frozen seafood to preserve quality during storage and distribution often was wrongly included as part of the labeled weight of seafood. In some instances, the investigation found, ice accounted for 40% of the product's weight.
The FDA is reviewing the situation to determine if any action should be taken. If there is a determination by the FDA that fraud is taking place, it will first issue a warning letter and later take "stronger action" if necessary.
http://www.chicagotribune.com/business/ct-biz-0331-fda-seafood--20100330,0,1741759.story
Hearing Announced to Consider Placement of Carisoprodol into Schedule IV.
The Drug Enforcement Administration (DEA) will hold a hearing with respect to the proposed placement of carisoprodol in schedule IV of the Controlled Substances Act on May 4, 2010. Interested persons desiring to participate in this hearing must provide written notice on or before April 26, 2010. This action may result in carisoprodol being subject to the regulatory controls and criminal sanctions of schedule IV, as are applicable to the manufacture, distribution, dispensing, importation, and exportation of carisoprodol and products containing carisoprodol. According to the DEA, carisoprodol products are being diverted, abused, misused, and sold on the street and from Internet sites without legitimate prescriptions, and it is being abused with other controlled drugs such as opioids. There are incidences of pain patients addicted to carisoprodol.
http://edocket.access.gpo.gov/2010/pdf/2010-6763.pdf
|